# CLIGAVYX

NDC: 83831-159
Generic name: fulvestrant
Labeler / Manufacturer: Avyxa Pharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20260701

FDA application: NDA210063

## Active ingredients

- FULVESTRANT: 250 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83831-159"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83831-159
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e20d8ca3-8837-4003-8b01-1ebec342062a